Functional studies on viable circulating tumor cells (v-CTCs) and frequent expression of PD-L1 on v-CTCs in pancreatic cancer

被引：0
|
作者：
Tanemura, Masahiro
Kashiwazaki, Masaki
Matsumoto, Kenichi
Furukawa, Kenta
Mikamori, Manabu
Asaoka, Tadafumi
Yamada, Daisaku
Kobayashi, Shogo
Eguchi, Hidetoshi
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5603
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PD-L1 expressing circulating tumor cells (CTCs) in patients with breast cancer
    Zavridou, Martha
    Strati, Areti
    Malamos, Nikos
    Georgoulias, Vasilis
    Lianidou, Evi S.
    CANCER RESEARCH, 2016, 76
  • [2] Clinical impact of viable circulating tumor cells (v-CTC) detection and PD-L1 expression on v-CTC in the patients with resectable pancreatic cancer
    Tanemura, Masahiro
    Furukawa, Kenta
    Mikamori, Manabu
    Saito, Takurou
    Otsuka, Masahisa
    Suzuki, Yozo
    Kishi, Kentaro
    Yasuoka, Hironao
    Tsujimoto, Masahiko
    Urata, Yasuo
    Akamatsu, Hiroki
    CANCER RESEARCH, 2019, 79 (13)
  • [3] Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC)
    Bergmann, Sonja
    Coym, Anja
    Ott, Leonie
    Soave, Armin
    Rink, Michael
    Janning, Melanie
    Stoupiec, Malgorzata
    Coith, Cornelia
    Peine, Sven
    von Amsberg, Gunhild
    Pantel, Klaus
    Riethdorf, Sabine
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [4] Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma of the bladder
    Bergmann, Sonja
    Coym, Anja
    von Amsberg, Gunhild
    Janning, Melanie
    Soave, Armin
    Rink, Michael
    Pantel, Klaus
    Riethdorf, Sabine
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Characterization of programmed cell death-1 ligand (PD-L1) expression in circulating tumor cells (CTCs) of lung cancer
    Krupa, Rachel
    Lu, David
    Graf, Ryon
    Louw, Jessica
    Dugan, Lyndsey
    Jendrisak, Adam
    Bethel, Kelly
    Wang, Yipeng
    Marrinucci, Dena
    Dittamore, Ryan
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S52 - S52
  • [6] Monitoring PD-L1 expression on circulating tumor cells (CTCs) in patients with NSCLC treated with PD1 inhibitors.
    Guibert, Nicolas Marie
    Delaunay, Myriam
    Lusque, Amellie
    Gouin, Sandrine
    Boubekeur, Nadia
    Rouquette, Isabelle
    Clermont, Estelle
    Fourtoul, Aurelien
    Favre, Gilles
    Pradines, Anne
    Mazieres, Julien
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [7] Characterization of PD-L1 expression in circulating tumor cells (CTCs) of non-small cell lung cancer (NSCLC) patients
    Krupa, R.
    Lu, D.
    Harvey, M.
    Louw, J.
    Jendrisak, A.
    Marrinucci, D.
    Dittamore, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 45 - 45
  • [8] Assessment of PD-L1 expression on circulating tumor cells (CTCs) and immune cells in peripheral blood of patients with small cell lung cancer (SCLC)
    Papadaki, M. A.
    Kapetanaki, E-E.
    Vorrias, E.
    Mavroudis, D.
    Agelaki, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1166 - S1166
  • [9] Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients
    Roumeliotou, Argyro
    Strati, Areti
    Chamchougia, Foteini
    Xagara, Anastasia
    Tserpeli, Victoria
    Smilkou, Stavroula
    Lagopodi, Elina
    Christopoulou, Athina
    Kontopodis, Emmanouil
    Drositis, Ioannis
    Androulakis, Nikolaos
    Georgoulias, Vassilis
    Koinis, Filippos
    Kotsakis, Athanasios
    Lianidou, Evi
    Kallergi, Galatea
    CELLS, 2024, 13 (09)
  • [10] Frequent expression of PD-L1 on circulating breast cancer cells
    Mazel, Martine
    Jacot, William
    Pantel, Klaus
    Bartkowiak, Kai
    Topart, Delphine
    Cayrefourcq, Laure
    Rossille, Delphine
    Maudelonde, Thierry
    Fest, Thierry
    Alix-Panabieres, Catherine
    MOLECULAR ONCOLOGY, 2015, 9 (09): : 1773 - 1782
12345